[Clinical trials with triethylene melamine].
D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid / Q000628:therapy*; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D014265:Triethylenemelamine / Q000627:therapeutic use*
D014265:Triethylenemelamine
HODGKIN'S DISEASE/therapy; LEUKEMIA, LYMPHATIC/therapy; LYMPHOSARCOMA/therapy; TRIETHYLENE MELAMINE/therapeutic use
Ensayos clänicos con tri-etileno-melamina (T.E.M.).